Literature DB >> 32360596

What factors modify the effect of monthly bolus dose vitamin D supplementation on 25-hydroxyvitamin D concentrations?

Zhenqiang Wu1, Carlos A Camargo2, Ian R Reid3, Angela Beros1, John D Sluyter1, Debbie Waayer1, Carlene M M Lawes1, Les Toop4, Kay-Tee Khaw5, Robert Scragg6.   

Abstract

The increasing use of vitamin D supplements has stimulated interest in identifying factors that may modify the effect of supplementation on circulating 25-hydroxyvitamin D (25(OH)D) concentrations. Such information is of potential interest to researchers, clinicians and patients when deciding on bolus dose of vitamin D supplementation. We carried out a large randomized controlled trial of 5110 adults aged 50-84 years, of European/Other (84%), Polynesian (11%) and Asian (5%) ethnicity, to whom we gave a standard dose of vitamin D3 supplements (200,000 IU initially, then 100,000 IU monthly) which was taken with high adherence. All participants provided a baseline blood sample, and follow-up blood samples were collected at 6 months and annually for 3 years in a random sample of 441 participants, and also at 2 years in 413 participants enrolled in a bone density sub-study. Serum 25(OH)D was measured by LC/MSMS. Mixed model analyses were carried out on all 854 participants providing follow-up blood samples in multivariable models that included age, sex, ethnicity, body mass index (kg/m2), tobacco smoking, alcohol intake, physical activity, sun exposure, season, medical prescription of high-dose vitamin D3 (Cal.D.Forte tablets), asthma/COPD and the study treatment (vitamin D or placebo). The adjusted mean difference in 25(OH)D in the follow-up points between vitamin D supplementation and placebo groups was inversely related (all p for interaction <0.05) to baseline 25(OH)D, BMI, and hours of sun exposure, and higher in females, elders, and those with high frequency of alcohol, medical prescription of vitamin D, and asthma/COPD. The mean difference was not significantly related to ethnicity (p = 0.12), tobacco (p = 0.34), and vigorous activity (p = 0.33). In summary, these data show that vitamin D status, BMI, sun exposure hours, sex and asthma/COPD modify the 25(OH)D response to vitamin D supplementation. By contrast, ethnicity, tobacco smoking, and vigorous activity do not.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  25-Hydroxyvitamin D; Effect modification; Randomized controlled trial; Vitamin D supplementation

Year:  2020        PMID: 32360596     DOI: 10.1016/j.jsbmb.2020.105687

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

1.  Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19.

Authors:  George Griffin; Martin Hewison; Julian Hopkin; Rose Anne Kenny; Richard Quinton; Jonathan Rhodes; Sreedhar Subramanian; David Thickett
Journal:  Clin Med (Lond)       Date:  2021-02-16       Impact factor: 2.659

2.  Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease.

Authors:  Maheshwar Lakkireddy; Srikanth Goud Gadiga; R D Malathi; Madhu Latha Karra; I S S V Prasad Murthy Raju; Sangeetha Chinapaka; K S S Sai Baba; Manohar Kandakatla
Journal:  Sci Rep       Date:  2021-05-20       Impact factor: 4.996

3.  Is There Proof of Extraskeletal Benefits From Vitamin D Supplementation From Recent Mega Trials of Vitamin D?

Authors:  Robert Scragg; John D Sluyter
Journal:  JBMR Plus       Date:  2021-01-04

Review 4.  Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis.

Authors:  J M Rhodes; S Subramanian; E Laird; G Griffin; R A Kenny
Journal:  J Intern Med       Date:  2020-07-22       Impact factor: 13.068

5.  Suboptimal Serum 25-Hydroxy-Vitamin D Is Associated with a History of Recent Disease Exacerbation in Pediatric Patients with Bronchial Asthma or Asthma-Suggestive Recurrent Wheezing.

Authors:  Teodora-Irina Adam-Bonci; Paraschiva Cherecheș-Panța; Eduard-Alexandru Bonci; Sorin Claudiu Man; Ancuța Cutaș-Benedec; Tudor Drugan; Raluca Maria Pop; Alexandru Irimie
Journal:  Int J Environ Res Public Health       Date:  2020-09-09       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.